Difference between revisions of "CDRT3"
(→Characteristics) |
(→Expression) |
||
| Line 13: | Line 13: | ||
===Expression=== | ===Expression=== | ||
| − | + | CDRT3 reveal no expression in adult tissues but obvious expression in fetal tissues.([http://www.ncbi.nlm.nih.gov/pubmed/11381029 (Inoue K 2001)]) | |
===Regulation=== | ===Regulation=== | ||
Revision as of 03:16, 28 July 2019
Contents
Annotated Information
Name
Approved symbol: CDRT3
Approved name: CMT1A duplicated region transcript 3
HGNC ID: HGNC:14382
RefSeq ID: NR_146601
Characteristics
Please input evolution information here.
Expression
CDRT3 reveal no expression in adult tissues but obvious expression in fetal tissues.((Inoue K 2001))
Regulation
Please input evolution information here.
Function
LeXis binds with heterogeneous ribonucleoprotein Raly which contains both an RNA-binding domain and a leucine-zipper coiled domain, to affect the expression of srebf2 gene, resulting to the change of the level of SREBP-2(sterol regulatory element-binding protein), to modulate cholesterol metabolism((Sallam T 2016)).
LeXis positively regulates CTNNB1 expression by functioning as a ceRNA against miR-199a to promote osteosarcoma growth((Wang G 2017)).
Disease
- osteosarcoma
- colon adenocarcinoma [1]
Evolution
Please input evolution information here.
Labs working on this lncRNA
- No.4 Department of Orthopedics, Cangzhou Central HospitalCangzhou, Hebei Province, China
- Department of Pathology and Laboratory Medicine, Howard Hughes Medical Institute, University of California, Los Angeles, California 90095, USA.
References
- ↑ Shahriyari L. Effect of normalization methods on the performance of supervised learning algorithms applied to HTSeq-FPKM-UQ data sets: 7SK RNA expression as a predictor of survival in patients with colon adenocarcinoma. Brief Bioinform. 2017 Nov 3. doi: 10.1093/bib/bbx153.
